The Europe bioinsecticides market was valued at USD 2.53 billion in 2023 and is anticipated to reach USD 2.99 billion in 2024 from USD 11.22 billion by 2032, growing at a CAGR of 18% from 2024 to 2032.
Insecticides are pesticides used to kill insects that cause damage to crops. Bioinsecticide is a biological-based insecticide is used to control insects and disease carriers like ticks, spiders, rats, etc., and is environmentally friendly. Every pest has its natural enemy which can be used to kill it. These Bioinsecticides are alternatives to some of the synthetic insecticides that pollute the environment and affect humans.
Major factors driving the market are the rise in crop loss due to insects and diseases, changing farming practices, and the development of pest resistance to various chemicals are some of the major factors driving the market. However, some of the factors like the Stringent Regulations on pesticide use is limiting the growth of the market.
Valent Biosciences Corporation, Syngenta AG, Bayer Crop Science AG, E. I. du Pont de Nemours and Company, Novozymes A/S, Koppert B.V. some of the market players that are dominating the Europe bioinsecticides market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region